[Federal Register Volume 80, Number 114 (Monday, June 15, 2015)]
[Notices]
[Page 34150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14574]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License for a U.S. Government-Owned 
Invention

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 
404.7(a)(1)(i), announcement is made of the intent to grant an 
exclusive, revocable license, to U.S. Provisional Patent No. 62/
086,355, filed December 2, 2014, entitled, ``Novel Regimens of 
Tafenoquine For Prevention of Malaria in Malaria-Na[iuml]ve Subjects,'' 
U.S. Patent No. 6,479,660, issued November 12, 2002, entitled, 
``Process for the Preparation of Anti-Malarial Drugs,'' and U.S. Patent 
No. 7,145,014, issued December 5, 2006, entitled ``Process for the 
Preparation of Quinoline Derivatives.'' The intended licensee is 
60[deg] Pharmaceuticals, LLC, with its principal place of business at 
1025 Connecticut Ave. NW., Suite 1000, Washington, DC 20036.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For licensing issues, Barry M. Datlof, 
Office of Research and Technology Applications (ORTA), (301) 619-0033. 
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-
7808, both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2015-14574 Filed 6-12-15; 8:45 am]
 BILLING CODE 3710-08-P